1. Academic Validation
  2. Downregulated circPOKE promotes breast cancer metastasis through activation of the USP10-Snail axis

Downregulated circPOKE promotes breast cancer metastasis through activation of the USP10-Snail axis

  • Oncogene. 2023 Sep 16. doi: 10.1038/s41388-023-02823-2.
Yan Luo 1 Qingyun Zhu 1 Shasha Xiang 1 Qi Wang 1 Jun Li 1 Xiguang Chen 1 Wen Yan 1 Jianbo Feng 2 Xuyu Zu 3
Affiliations

Affiliations

  • 1 Cancer Research Institute, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, PR China.
  • 2 Cancer Research Institute, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, PR China. [email protected].
  • 3 Cancer Research Institute, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, PR China. [email protected].
Abstract

Breast Cancer (BC) is the most commonly diagnosed Cancer and the leading cause of cancer-related death among females. Metastasis accounts for the majority of BC related deaths. One feasible strategy to solve this challenging problem is to disrupt the capabilities required for tumor metastasis. Herein, we verified a novel metastasis suppressive circRNA, circPOKE in BC. circPOKE was downregulated in primary and metastatic BC tissues and overexpression of circPOKE inhibited the metastatic potential but not the proliferative ability of BC cells in vitro and in vivo. Mechanistically, circPOKE competitively binds to USP10, and reduces its binding to Snail, a key transcriptional regulator of EMT, thereby inhibiting Snail stability via the protein-ubiquitination degradation pathway. In addition, we found that circPOKE could be secreted into the extracellular space via exosomes and that exosome-carried circPOKE significantly inhibited the invasive capabilities of BC cells in vitro and in vivo. Furthermore, the levels of circPOKE, USP10 and Snail are clinically relevant in BC, suggesting that circPOKE may be used as a potential therapeutic target for patients with BC metastasis.

Figures
Products